Background
==========

High-grade B-cell non-Hodgkin's lymphoma (NHL), Kaposi's sarcoma, and invasive cervical cancer are 3 AIDS-defining malignancies. Since the introduction of combined antiretroviral therapy (cART), HIV-related lymphomas have increased as a percentage of first AIDS-defining illness, in particular diffuse large B-cell lymphoma (DLBCL) \[[@b1-amjcaserep-18-1135]\]. Immunosuppression is the primary culprit leading to lymphomas \[[@b2-amjcaserep-18-1135]\], and immune reconstitution with cART is considered to be an important factor in maintaining long-term lymphoma remission \[[@b3-amjcaserep-18-1135]\]. It is well known that swollen painless lymph nodes are the most common symptoms of systemic lymphoma. Here, we report a case of DLBCL with 3 fast-growing large subcutaneous tumors located in the right groin and the chest wall, accompanied with unilateral lower-extremity edema and rib lesions.

Case Report
===========

A 41-year-old man complained of a 3-month history of a fast-growing lymph node in the right groin, and a 2-month history of 3 subcutaneous tumors in the right posterior chest wall and the right lateral chest wall. One month ago, the man began to experience right groin pain and surface ulceration and crusting of the swollen lymph node, resulting in right lower-extremity swelling and limited mobility. During the course of this case, the man complained of over 5 kg of weight loss, but not symptoms of fever, night sweat, hemorrhage, cough, or chest pain. He had a history of blood transfusion about 20 years ago, but had no history of sexual contact with men. A physical examination showed a tumor 20×15 cm in diameter in the right groin, with surface ulceration and crusting, high local skin temperature and tenderness, accompanied with scrotum swelling, right lower-extremity pitting edema, and weakened right dorsalis pedis artery pulse ([Figure 1A--1D](#f1-amjcaserep-18-1135){ref-type="fig"}). Further, a painless subcutaneous tumor 16×9 cm in diameter was located in the right lateral chest wall, and another 2 circle subcutaneous tumors (7 cm and 3 cm in diameter) were found in the right posterior chest wall ([Figure 1E, 1F](#f1-amjcaserep-18-1135){ref-type="fig"}). The systemic examination was otherwise unremarkable. Laboratory tests showed positive serum anti-HIV antibody and further Western blot analysis confirmed his HIV infection. The results of laboratory tests taken on admission are shown in [Table 1](#t1-amjcaserep-18-1135){ref-type="table"}. A thoracic CT scan showed bilateral pleural effusion and the right chest wall tumors with rib lesions ([Figure 2A--2C](#f2-amjcaserep-18-1135){ref-type="fig"}). A pelvic and leg CT showed right inguinal masses and multiple swollen lymph nodes in retroperitoneal and pelvic areas ([Figure 2D--1F](#f2-amjcaserep-18-1135){ref-type="fig"}). Color Doppler ultrasound did not show any lower-extremity deep venous thrombosis. A needle biopsy of the right groin mass was performed and the histology revealed many medium-to-large-sized lymphocytes with oval or round nuclei containing fine chromatin scanty and cytoplasm ([Figure 3](#f3-amjcaserep-18-1135){ref-type="fig"}). Immunohistochemistry was consistent with a diagnosis of DLBCL ([Figure 3](#f3-amjcaserep-18-1135){ref-type="fig"}). The patient had no lymphoma cells in his bone marrow but had a loss of over 10% body weight within the previous 6 months. Furthermore, the lymph node regions were on both sides of the diaphragm and 1 extra-lymphatic organ (rib) was involved. Therefore, this case of NHL was classified as stage IIIE, B group.

The patient and his family refused chemotherapy or radiotherapy for lymphoma due to financial and other reasons, and decided to leave the hospital and receive oral cART, including tenofovir (300 mg once per day), lamivudine (300 mg once per day), and efavirenz (600 mg once per day) at home.

Discussion
==========

DLBCL accounts for the large majority of AIDS-related NHL \[[@b3-amjcaserep-18-1135]\]. Even among non-HIV infected people, about one-third of newly diagnosed NHL is DLBCL in the United States \[[@b4-amjcaserep-18-1135]\]. DLBCL usually arise in lymph nodes, presenting as a painless rapidly swelling mass in the neck, armpit, or groin. Sometimes, organs outside the lymphatic system are involved in this pathology \[[@b5-amjcaserep-18-1135]\]. The speed of growth of the mass correlates to the lymphoma stage, and high-stage lymphoma often grows rapidly, but a rapidly progressing lymphoma tumor often grows for over 6 months \[[@b6-amjcaserep-18-1135]\]. Thus, our report of DLBCL in a AIDS patient which only took 3 months to develop a tumor 20×15 cm in diameter is rare. Furthermore, although an enlarged lymph node in the groin can theoretically cause scrotum swelling and lower-extremity edema, unilateral lower-extremity edema is a rare initial presentation for lymphoma \[[@b7-amjcaserep-18-1135],[@b8-amjcaserep-18-1135]\]. It was doubtful that this rapid lymphoma growth was correlated with the severe immunosuppression because this patient had a CD4 cell count of 411 cells/μL.

Most chest-wall tumors arise from metastasis, and primary chest wall and pulmonary lymphoma is extremely rare \[[@b9-amjcaserep-18-1135]\]. Shah et al. reported a case of a 52-year-old female patient who presented with a primary chest wall DLBCL \[[@b10-amjcaserep-18-1135]\]. Lau et al. reported a case of DLBCL with a chronic unilateral-sided pleural effusion, but without rib destruction \[[@b11-amjcaserep-18-1135]\]. Qiu et al. reported the case of an elderly man with a primary chest wall DLBCL who presented with unilateral-sided chest pain and a solid mass in the interior chest wall \[[@b12-amjcaserep-18-1135]\]. Interestingly, Ueda et al. reported a primary chest wall marginal zone B-cell lymphoma with a 15-year history of a right chest wall mass lesion without any symptoms or evidence of malignancy \[[@b13-amjcaserep-18-1135]\]. Therefore, a chest wall lymphoma is rare and such a rapidly-growing chest wall lymphoma with rib lesions is extremely rare.

Conclusions
===========

Although DLBCL accounts for the large majority of AIDS-related NHL, it is rare that a DLBCL took 3 months to develop a tumor 20×15 cm in diameter and even caused scrotum swelling and unilateral lower-extremity edema due to the large mass located in the right groin. Furthermore, it is extremely rare that this lymphoma infiltrated the chest wall and even resulted in rib lesions. We present the clinical characteristics of this case to help clinicians in making a timely definitive diagnosis of this disease.

![(**A--F**) Morphological presentations of the tumors.](amjcaserep-18-1135-g001){#f1-amjcaserep-18-1135}

![CT presentations of the tumors. (**A, B**) A thoracic CT scan showed right chest wall tumors (the sword denotes chest wall tumor). (**C**) A thoracic CT scan showed right chest wall tumors with rib lesions and right pleural effusion (the sword denotes chest wall tumor with rib lesion). (**D**) A pelvic CT showed right inguinal mass (the sword denotes right inguinal mass). (**E**) A leg CT scan showed right inguinal mass (the sword denotes right inguinal mass). (**F**) A leg CT scan showed right subcutaneous soft-tissue swelling.](amjcaserep-18-1135-g002){#f2-amjcaserep-18-1135}

![Pathological morphology of the right groin mass biopsy. The morphology showed the following immunohistochemistry results: Ki67(≥95% +), P53(+), CD20(+++), CD3(minor+), Vimentin(+++), CD79a(+++), Bcl-2(−), Bcl-6(+), and CD10(++).](amjcaserep-18-1135-g003){#f3-amjcaserep-18-1135}

###### 

Laboratory test results on admission.

  **Plasma sample**                         **Test value**   **Normal range**   **Plasma sample**                            **Test value**   **Normal range**
  ----------------------------------------- ---------------- ------------------ -------------------------------------------- ---------------- ------------------
  White blood cell counts (10^9^/L)         7.12             3.5--9.5           High-sensitivity C-reactive protein (mg/L)   46.0             0--10
  Neutrophils percentage (%)                61.9             40--75             Procalcitonin (ng/ml)                        \<0.05           \<0.1
  Lymphocyte percentage (%)                 31.6             20--50             Anti-human immunodeficiency virus antibody   Positive         Negative
  Hemoglobin (g/L)                          130.0            130--175           Plasma (1,3) beta-D-glucan (pg/mL)           78.4             \<60
  Platelets (10^9^/L)                       314              125--350           Carcino-embryonic antigen (ng/ml)            0.456            0--4.7
  Blood urea nitrogen (mmol/L)              5.54             2.9--8.2           Carbohydrate antigen 19-9 (U/ml)             6.48             0--27
  Creatinine (μmol/L)                       73.9             59--104            Carbohydrate antigen 72-4 (U/ml)             6.59             0--6.9
  Alanine transarninase (U/L)               21.9             9--50              Carbohydrate antigen 125 (U/ml)              62.10            0--35
  Glutamic-oxal acetic transaminase (U/L)   25.4             15--40             Carbohydrate antigen 15-3 (U/ml)             6.11             0--25
  Total bilirubin (µmol/L)                  8.2              5--21              Neuron-specific enolase (ng/ml)              49.36            0--16.3
  Direct bilirubin (µmol/L)                 3.1              \<7                Cytokeratin protein fragment 21-1 (ng/ml)    5.940            0--3.3
  Albumin (g/L)                             41.0             40--55             Total prostate-specific antigen (ng/ml)      0.256            0--2.0
  CD4 cell counts (cells/μL)                411.0            544--1212          Free prostate-specific antigen (ng/ml)       0.074            0--0.934
  Erythrocyte sedimentation rate (mm/hr)    17.0             0--15              Ferritin (ng/ml)                             441.10           30--400
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